First FDA cleared product based on the Company's proprietary MultiPath technology
Funding Supports Continued Development of the SensiTox™ B. anthracis Toxin Test
Life Sciences Veteran Andrew Wilsack Joins Team
New videos include 1-1 clinician interviews and detailed product tour
Additional funds to support the company's diagnostic platform initiatives